Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Medical and health teaching and research at Oxford University has been ranked as the world's best for the sixth year running in the Times Higher Education World University Rankings.

The discipline-specific tables, released today, follow on from last week's announcement that Oxford has been ranked the top university in the world by the same publication – the first time a UK institution has been awarded the accolade.

The ranking of clinical, pre-clinical and health subjects is based on criteria measuring teaching, research, industry income, international outlook and citations, all of which are combined to provide a well-regarded comparison of universities worldwide.

Professor Alastair Buchan, Dean of Medicine and Head of the Medical Sciences Division at Oxford University, said: 'We are delighted to have come first in clinical, pre-clinical and health subjects for the sixth year running. This success is because of the quality of our students, who come to Oxford because of the quality of our faculty. We are pleased to be able to house students in a fully integrated basic science, translational science, clinical science and population health division, which has a global impact, especially through our overseas units.'

The Medical Sciences Division is a significant part of the University of Oxford, with around 5,000 full-time equivalent researchers, teachers and staff, 1,500 graduate and 1,500 undergraduate students. As one of the largest biomedical research centres in Europe, it carries out a considerable number of clinical trials to develop new treatments and to improve patient care and safety. Both research and clinical trials are supported by a network of international research units in Africa and Asia.

Key to the division's success is its close partnership with the NHS in Oxfordshire, including the Oxford University Hospitals and Oxford Health NHS Foundation Trusts. This means that lessons from the day-to-day experience of real-life patient care are used to improve the University's research and teaching, while the latest developments in medical research are used to improve patient care.

The Medical Sciences Division has enjoyed a successful year, including faculty member Professor Sir Peter Ratcliffe receiving a prestigious Lasker Award for his work understanding the mechanisms by which cells sense and signal low oxygen levels. Earlier this month, Oxford University and local NHS partners were awarded £126.5m by the National Institute for Health Research to support medical research, while other highlights have included the world's first eye operation using a robot, performed by Professor Robert MacLaren, and the first results being reported from the UK's largest study into treatments for prostate cancer.

Similar stories

New Cochrane evidence explores treatment options for chronic ear disease

Publication Research

A new Evidently Cochrane blog post for World Hearing Day summarises seven recent reviews on medical treatments for infection and inflammation of the middle ear.

New reporting guidelines to bridge the gap from development to implementation in clinical artificial intelligence

Innovation Research

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Cochrane ENT awarded NIHR funding for COVID-19 project

Awards and appointments Coronavirus COVID-19 Research

Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.

First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy

Coronavirus COVID-19 Publication Research

Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.

Applications for Oxford-Wolfson-Marriott-Patel Scholarship now open

Awards and appointments Department Research

The Nuffield Department of Surgical Sciences (NDS) are pleased to confirm that one scholarship will be available for Home (UK) and Republic of Ireland (ROI) candidates for the DPhil in Surgical Sciences, starting in Michaelmas Term 2021.

Oxford University breakthrough on global COVID-19 vaccine

Coronavirus COVID-19 Research

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.